193 related articles for article (PubMed ID: 32193764)
1. Prevalence of Mismatch Repair-Deficient Colorectal Adenoma/Polyp in Early-Onset, Advanced Cases: a Cross-Sectional Study Based on Iranian Hereditary Colorectal Cancer Registry.
Khorram MR; Goshayeshi L; Maghool F; Bergquist R; Ghaffarzadegan K; Eslami S; Khooei A; Hoseini B
J Gastrointest Cancer; 2021 Mar; 52(1):263-268. PubMed ID: 32193764
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinicopathological characteristics of mismatch repair-deficient colorectal carcinoma in early onset cases as compared with late-onset cases: a retrospective cross-sectional study in Northeastern Iran.
Goshayeshi L; Ghaffarzadegan K; Khooei A; Esmaeilzadeh A; Rahmani Khorram M; Mosannen Mozaffari H; Kiani B; Hoseini B
BMJ Open; 2018 Aug; 8(8):e023102. PubMed ID: 30166308
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry.
Walsh MD; Buchanan DD; Pearson SA; Clendenning M; Jenkins MA; Win AK; Walters RJ; Spring KJ; Nagler B; Pavluk E; Arnold ST; Goldblatt J; George J; Suthers GK; Phillips K; Hopper JL; Jass JR; Baron JA; Ahnen DJ; Thibodeau SN; Lindor N; Parry S; Walker NI; Rosty C; Young JP
Mod Pathol; 2012 May; 25(5):722-30. PubMed ID: 22322191
[TBL] [Abstract][Full Text] [Related]
4. Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas.
Pino MS; Mino-Kenudson M; Wildemore BM; Ganguly A; Batten J; Sperduti I; Iafrate AJ; Chung DC
J Mol Diagn; 2009 May; 11(3):238-47. PubMed ID: 19324997
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
[TBL] [Abstract][Full Text] [Related]
6. Routine Molecular Analysis for Lynch Syndrome Among Adenomas or Colorectal Cancer Within a National Screening Program.
Goverde A; Wagner A; Bruno MJ; Hofstra RMW; Doukas M; van der Weiden MM; Dubbink HJ; Dinjens WNM; Spaander MCW
Gastroenterology; 2018 Nov; 155(5):1410-1415. PubMed ID: 30063919
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of altered mismatch repair protein nuclear expression detected by immunohistochemistry on adenomas with high-grade dysplasia and features associated with this risk in a population-based study].
Basterra M; Gomez M; Mercado Mdel R; Irisarri R; Amorena E; Arrospide A; Montes M; Aisa G; Cambra KI; Urman J
Gastroenterol Hepatol; 2016 Oct; 39(8):500-7. PubMed ID: 26790715
[TBL] [Abstract][Full Text] [Related]
8. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
9. Molecular Screening for Lynch Syndrome in Young Patients With Colorectal Adenomas.
Mendelsohn RB; Herzog K; Shia J; Rahaman N; Stadler ZK; Shike M
Clin Colorectal Cancer; 2017 Sep; 16(3):173-177. PubMed ID: 28242162
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2.
Liljegren A; Barker G; Elliott F; Bertario L; Bisgaard ML; Eccles D; Evans G; Macrae F; Maher E; Lindblom A; Rotstein S; Nilsson B; Mecklin JP; Möslein G; Jass J; Fodde R; Mathers J; Burn J; Bishop DT
J Clin Oncol; 2008 Jul; 26(20):3434-9. PubMed ID: 18612159
[TBL] [Abstract][Full Text] [Related]
11. Mismatch repair deficiency in Lynch syndrome-associated colorectal adenomas is more prevalent in older patients.
Tanaka M; Nakajima T; Sugano K; Yoshida T; Taniguchi H; Kanemitsu Y; Nagino M; Sekine S
Histopathology; 2016 Aug; 69(2):322-8. PubMed ID: 26826556
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
[TBL] [Abstract][Full Text] [Related]
14. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps.
Yurgelun MB; Goel A; Hornick JL; Sen A; Turgeon DK; Ruffin MT; Marcon NE; Baron JA; Bresalier RS; Syngal S; Brenner DE; Boland CR; Stoffel EM
Cancer Prev Res (Phila); 2012 Apr; 5(4):574-82. PubMed ID: 22262812
[TBL] [Abstract][Full Text] [Related]
16. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
17. The contribution of Lynch syndrome to early onset malignancy in Ireland.
Talbot A; O'Donovan E; Berkley E; Nolan C; Clarke R; Gallagher D
BMC Cancer; 2021 May; 21(1):617. PubMed ID: 34039291
[TBL] [Abstract][Full Text] [Related]
18. Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas.
Ju JY; Mills AM; Mahadevan MS; Fan J; Culp SH; Thomas MH; Cathro HP
Am J Surg Pathol; 2018 Nov; 42(11):1549-1555. PubMed ID: 30148743
[TBL] [Abstract][Full Text] [Related]
19. Universal screening to identify Lynch syndrome: two years of experience in a Northern Italian Center.
Chiaravalli AM; Carnevali I; Sahnane N; Leoni E; Furlan D; Berselli M; Sessa F; Tibiletti MG
Eur J Cancer Prev; 2020 Jul; 29(4):281-288. PubMed ID: 31609810
[TBL] [Abstract][Full Text] [Related]
20. Detection of DNA mismatch repair deficient crypts in random colonoscopic biopsies identifies Lynch syndrome patients.
Brand RE; Dudley B; Karloski E; Das R; Fuhrer K; Pai RK; Pai RK
Fam Cancer; 2020 Apr; 19(2):169-175. PubMed ID: 31997046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
